CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $19.04M, above the global median of $16.24M
- PositionCurrent ratio is 1.13×, lower than 95% of its Scientific & Technical Instruments peers (median 2.39×)
- Interpretations4 currently firing — 4
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.82BCNY419.29M · vs all stocks (USD)
Trailing P/E
69.58xvs Scientific & Technical Instruments peers
Revenue (TTM)
930.94MCNY138.26M · vs all stocks (USD)
Profit Margin
4.30%vs Scientific & Technical Instruments peers
Beta
1.38xvs all stocks
52-Week Change
-11.00%vs all stocks
Market Capitalization
2.82BCNY419.29M · vs all stocks (USD)
Enterprise Value
3.19BCNY473.79M · vs all stocks (USD)
Trailing P/E
69.58xvs Scientific & Technical Instruments peers
Forward P/E
4.54xvs Scientific & Technical Instruments peers
Price to Sales (TTM)
3.29xvs Scientific & Technical Instruments peers
Price to Book (MRQ)
11.12xvs Scientific & Technical Instruments peers
Enterprise to Revenue
3.43xvs Scientific & Technical Instruments peers
Enterprise to EBITDA
43.26xvs Scientific & Technical Instruments peers
Gross Margin
25.36%vs Scientific & Technical Instruments peers
Profit Margin
4.30%vs Scientific & Technical Instruments peers
Operating Margin
8.85%vs Scientific & Technical Instruments peers
Return on Assets (TTM)
2.50%vs Scientific & Technical Instruments peers
Return on Equity (TTM)
14.74%vs Scientific & Technical Instruments peers
Revenue (TTM)
930.94MCNY138.26M · vs all stocks (USD)
Revenue per Share (TTM)
2.53CNYUpdated Aug 19, 2026Quarterly Revenue Growth
37.90%vs Scientific & Technical Instruments peers
Gross Profit (TTM)
260.54MCNY38.70M · vs all stocks (USD)
EBITDA (TTM)
53.77MCNY7.99M · vs all stocks (USD)
Net Income (TTM)
40.07MCNY5.95M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
34.60%vs Scientific & Technical Instruments peers
Operating Cash Flow (TTM)
82.35MCNY12.23M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
128.19MCNY19.04M · vs all stocks (USD)
Payout Ratio
0.00%vs Scientific & Technical Instruments peers
Minority Interest (Equity)
-180.02KCNYFY2025 · Dec 31, 2025Revenue
869.22MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
597.83MCNYFY2025 · Dec 31, 2025Gross Profit
271.40MCNYFY2025 · Dec 31, 2025Operating Income
55.06MCNY8.18M · vs all stocks (USD)
Pre-tax Income
34.81MCNYFY2025 · Dec 31, 2025Income Tax Expense
1.64MCNYFY2025 · Dec 31, 2025Net Income
33.17MCNYFY2025 · Dec 31, 2025EBIT
50.33MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
64.23MCNYFY2025 · Dec 31, 2025Research & Development
39.18MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
50.27MCNYFY2025 · Dec 31, 2025Other Operating Expenses
9.74MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
825.26KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
15.52MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.1000CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.1000CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
367.76MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
367.76MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
33.17MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
3.61MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
20.45MCNYFY2025 · Dec 31, 2025Free Cash Flow
-38.60MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
121.38MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
33.17MCNYFY2025 · Dec 31, 2025Other Non-cash Items
19.30MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-54.84MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
22.83MCNYFY2025 · Dec 31, 2025Capital Expenditures
59.05MCNYFY2025 · Dec 31, 2025Other Investing Activity
-10.87MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
48.18MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
339.84MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-340.50MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-13.88MCNYFY2025 · Dec 31, 2025Other Financing Charges
-16.56MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-31.10MCNYFY2025 · Dec 31, 2025Shares Outstanding
367.11MSharesUpdated Aug 19, 2026Float Shares
283.81MSharesUpdated Aug 19, 2026% Held by Insiders
24.38%vs all stocks
% Held by Institutions
1.18%vs all stocks
Total Cash (MRQ)
266.83MCNY39.63M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.7270CNYUpdated Aug 19, 2026Total Debt (MRQ)
389.53MCNY57.85M · vs all stocks (USD)
Total Debt to Equity (MRQ)
1.40xvs Scientific & Technical Instruments peers
Current Ratio (MRQ)
1.13xvs Scientific & Technical Instruments peers
Book Value per Share (MRQ)
0.7510CNYUpdated Aug 19, 2026Total Assets
1.43BCNY212.17M · vs all stocks (USD)
Total Current Assets
1.15BCNYFY2025 · Dec 31, 2025Total Liabilities
1.17BCNYFY2025 · Dec 31, 2025Total Non-current Assets
280.44MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
154.54MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.01BCNYFY2025 · Dec 31, 2025Cash
133.39MCNYFY2025 · Dec 31, 2025Cash Equivalents
48.00MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
181.39MCNYFY2025 · Dec 31, 2025Accounts Receivable
263.43MCNYFY2025 · Dec 31, 2025Inventory
503.18MCNYFY2025 · Dec 31, 2025Accounts Payable
309.96MCNYFY2025 · Dec 31, 2025Short-term Debt
236.74MCNYFY2025 · Dec 31, 2025Other Current Liabilities
51.61MCNYFY2025 · Dec 31, 2025Long-term Debt
120.20MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
15.42MCNYFY2025 · Dec 31, 2025Common Stock (Book)
367.11MCNYFY2025 · Dec 31, 2025Retained Earnings
-1.27BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
262.81MCNY39.03M · vs all stocks (USD)
52-Week Low
5.90CNYUpdated Aug 19, 202652-Week High
13.62CNYUpdated Aug 19, 202652-Week Change
-11.00%vs all stocks
Beta
1.38xvs all stocks
50-Day MA
9.18CNYUpdated Aug 19, 2026200-Day MA
9.15CNYUpdated Aug 19, 2026Avg 10-Day Volume
20.18MSharesUpdated Aug 19, 2026Avg 30-Day Volume
21.08MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
0.1200CNYUpdated Aug 19, 20264 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Diagnostic
Elevated ROE With High Debt-to-Equity and Equity Multiplier
Return on equity reads high on a balance sheet carrying a lot of debt against that equity.
Reads
Where is this company structurally exposed?
Within or Near the Altman Distress Zone
Debt is a large share of its assets, and large against its cash flow.
Reads
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Elevated Leverage on Three Denominators
Debt sits high against its equity, its assets, and its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Current ratio is 1.13×, lower than 95% of its Scientific & Technical Instruments peers (median 2.39×)Significant
Current ratio: 1.13Industry median: 2.39Industry P5: 1.21Peers compared: 64.00
Debt-to-equity is 1.4×, higher than 95% of its Scientific & Technical Instruments peers (median 0.13×)Significant
Debt-to-equity: 1.40Industry median: 0.13Industry P95: 1.01Peers compared: 64.00
Price-to-book is 11.12×, higher than 95% of its Scientific & Technical Instruments peers (median 3.34×)Significant
Price-to-book: 11.12Industry median: 3.34Industry P95: 8.24Peers compared: 64.00
Financial Health
Altman Z-Score 1.05: distress zoneCritical
Altman Z-Score: 1.05
Supply Chain
Midstream position: 6 outgoing, 4 incoming connectionsNotable
Outgoing: 6.00Incoming: 4.00
High connectivity hub: 10 industry connectionsNotable
Total Connections: 10.00
Scale
Levered free cash flow is $19.04M, above the global median of $16.24MNotable
Levered free cash flow (USD): 19,038,645.726Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Ecogreen Enerji Holding Anonim Sirketi
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Chongqing Yuxin Pingrui Electrical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shanghai Dragon Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Guangdong Nedfon Air System Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Liaoning Hezhan Energy Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Jiangxi Selon Industrial Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Lets Holdings Group Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Guangdong Huiyun Titanium Industry Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Izmir Demir Celik Sanayi A.S.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiangsu Flag Chemical Industry Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Cecep Techand Ecology & Environment Co., Ltd.
3 interpretationsElevated Leverage on Three DenominatorsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedWithin or Near the Altman Distress Zone
Eagle High Plantations Tbk
4 interpretationsElevated Leverage on Three DenominatorsElevated ROE With High Debt-to-Equity and Equity MultiplierUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedWithin or Near the Altman Distress Zone
Eternal Asia Supply Chain Co., Ltd.
3 interpretationsElevated Leverage on Three DenominatorsUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedWithin or Near the Altman Distress Zone